Scanlon
Daire Scanlon, Limerick IE
Patent application number | Description | Published |
---|---|---|
20140074505 | SYSTEM AND METHOD FOR MANAGING THE DISTRIBUTION OF MEDICATION TO PATIENTS - A system for managing the distribution of medication to patients. The system comprises a point of care (POC) device which is configured for creating digital medical prescriptions for individual patients. A data repository is provided which is associated with the POC device and is operable for storing the digital medical prescriptions. A computer is provided which is in communication with the data repository and is operable for retrieving the digital medical prescriptions therefrom. The computer is configured to generate respective labels containing at least one identifier that associates a medication of a digital medical prescription to a particular patient. | 03-13-2014 |
Denis Bernard Scanlon, South Austrailia AU
Patent application number | Description | Published |
---|---|---|
20110293517 | Nitrogen-Containing Macrocyclic Conjugates As Radiopharmaceuticals - The present invention relates to compounds that are useful as metal ligands and which either contain a molecular recognition moiety or can be bound to a molecular recognition moiety and methods of making these compounds. Once the compounds that contain a molecular recognition moiety are coordinated with a suitable metallic radionuclide, the coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging. The invention therefore also relates to methods of diagnosis and therapy utilising the radiolabelled compounds of the invention. | 12-01-2011 |
Jane Scanlon, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20100210639 | 9H-PYRIMIDO[4,5-B]INDOLES, 9H-PYRIDO[4',3':4,5]PYRROLO[2,3-D]PYRIDINES, AND 9H 1,3,6,9 TETRAAZA-FLUORENES AS CHK1 KINASE FUNCTION INHIBITORS - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain tricyclic compounds (referred to herein as TC compounds), and especially certain 9H-pyrimido[4,5-b]indole, 9H-pyrido[4′,3′:4,5]pyrrolo[2,3-d]pyridine, and 9H-1,3,6,9-tetraaza-fluorene compounds, which, inter alia, inhibit Checkpoint Kinase 1 (CHK1) kinase function. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit CHK1 kinase function, and in the treatment of diseases and conditions that are mediated by CHK1, that are ameliorated by the inhibition of CHK1 kinase function, etc., including proliferative conditions such as cancer, etc., optionally in combination with another agent, for example, (a) a DNA topoisomerase I or II inhibitor; (b) a DNA damaging agent; (c) an antimetabolite or TS inhibitor; (d) a microtubule targeted agent; and (e) ionising radiation. | 08-19-2010 |
Jane Elizabeth Scanlon, Cambridgeshire GB
Patent application number | Description | Published |
---|---|---|
20100331328 | BICYCLYLARYL-ARYL-AMINE COMPOUNDS AND THEIR USE - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain bicyclylaryl-aryl-amines compounds of the following formula (referred to herein as BCAA compounds), which, inter alia, inhibit Checkpoint Kinase 1 (CHK1) kinase function. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit CHK1 kinase function, and in the treatment of diseases and conditions that are mediated by CHK1, that are ameliorated by the inhibition of CHK1 kinase function, etc., including proliferative conditions such as cancer, etc., optionally in combination with another agent, for example, (a) a DNA topoisomerase I or II inhibitor; (b) a DNA damaging agent; (c) an antimetabolite or TS inhibitor; (d) a microtubule targeted agent; and (e) ionising radiation: | 12-30-2010 |
Jane Elizabeth Scanlon, Sawston GB
Patent application number | Description | Published |
---|---|---|
20120040967 | Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine Compounds and Their Use - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain biarylamine compounds (referred to herein as BAA compounds), and especially certain pyrazin-2-yl-pyridin-2-yl-amine and pyrazine-2-yl-pyrimidin-4-yl-amine compounds, which, inter alia, inhibit Checkpoint Kinase 1 (CHK1) kinase function. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit CHK1 kinase function, and in the treatment of diseases and conditions that are mediated by CHK1, that are ameliorated by the inhibition of CHK1 kinase function, etc., including proliferative conditions such as cancer, etc., optionally in combination with another agent, for example, (a) a DNA topoisomerase I or II inhibitor; (b) a DNA damaging agent; (c) an antimetabolite or TS inhibitor; (d) a microtubule targeted agent; and (e) ionising radiation. | 02-16-2012 |
20140179664 | Heterocyclyl Pyrimidine Analogues As JAK Inhibitors - The present invention relates to compounds of formula (I) | 06-26-2014 |
Jane Elizabeth Scanlon, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20120065202 | PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS - The invention relates to compounds of formula (I) | 03-15-2012 |
20140163023 | DIHYDROPYRROLO PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS - The invention relates to compounds of formula (I) | 06-12-2014 |
20140296234 | PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS - The invention relates to compounds of formula (I) | 10-02-2014 |
Janet Susan Scanlon, West Cheshunt GB
Patent application number | Description | Published |
---|---|---|
20110089386 | Phase change materials with improved fire-retardant properties - The present invention provides latent heat storage materials having enhanced fire-retardant properties. These include compositions of magnesia cement and a phase change material in which the magnesia cement is formed from magnesium oxide, magnesium chloride, and water. The molar ratio of magnesium chloride to water may be in the range of about 1:17 to 1:32. The magnesium chloride may be dissolved in the water to give a solution having a Baumé in the range between 15° and 26°. The molar ratio of magnesium chloride to magnesium oxide may be in the range of about 1:1 to about 1:5, and the latent heat storage material may additionally comprises fillers, and/or intumescent agents. The phase change material may be a microencapsulated formulation. A process for making these compositions is disclosed. | 04-21-2011 |
20110089387 | Phase change materials with improved fire-retardant properties - The present invention provides latent heat storage materials having enhanced fire-retardant properties. These include compositions a phase change material and a binder, the binder including dry inert powder, phosphogypsum, and an alkaline salt of any metal. The latent heat storage material may additionally comprise magnesia cement including magnesium oxide, magnesium chloride, and water. The latent heat storage material may additionally comprises fillers, and/or intumescent agents. The phase change material may be a microencapsulated formulation. A process for making these compositions is disclosed. | 04-21-2011 |
Patricia Scanlon, Portobello IE
Patent application number | Description | Published |
---|---|---|
20090305665 | METHOD OF IDENTIFYING A TRANSMITTING DEVICE - An exemplary method of identifying a transmitting device includes receiving a signal. A discrete Fourier transform of at least one portion of the signal produces a plurality of frequencies that indicate at least one unique characteristic of the transmitting device. A determination is made whether the transmitting device is a known device based upon the plurality of frequencies. | 12-10-2009 |
Shane Scanlon, Leeds GB
Patent application number | Description | Published |
---|---|---|
20140206534 | FORMULATION - The present invention relates to a process for coating a surface with micelles which comprise an AB block copolymer comprising the step of treating the surface with an apolar liquid containing the micelles; and to surfaces coated with such micelles. | 07-24-2014 |
20140249031 | MICELLE-COATED CRYSTALLINE PARTICLES - The present invention relates to crystalline particles [particularly organic particles or agrochemical particles] coated with micelles of copolymers, to compositions comprising such particles, to a process for preparing the coated particles and to uses of the particles and the compositions [for example to produce surface coatings with high loadings of copolymer and uses of products derived therefrom]. | 09-04-2014 |
Terry Scanlon, County Clare IE
Patent application number | Description | Published |
---|---|---|
20130276970 | INDEXABLE CUTTER INSERT, CONSTRUCTION FOR SAME AND METHOD FOR MAKING SAME - A method of making a construction for an indexable cutter insert, the method including providing a wafer ( | 10-24-2013 |
Terry Scanlon, Co. Clare IE
Patent application number | Description | Published |
---|---|---|
20130302101 | TWIST DRILL ASSEMBLY, COMPONENTS FOR SAME AND METHOD FOR MAKING SAME - A twist drill assembly ( | 11-14-2013 |
Timothy J. Scanlon, Derby GB
Patent application number | Description | Published |
---|---|---|
20120227414 | GAS TURBINE ENGINE SWIRLED COOLING AIR - A gas turbine engine has in flow series a compressor section, a combustor, and a turbine section. The engine includes a turbine section rotor disc, and a stationary wall forward of a front face or rearward of a rear face of the rotor disc. The wall defines a cavity between the stationary wall and the rotor disc, and has a plurality of air entry nozzles through which cooling air can be delivered into the cavity at an inlet swirl angle. The engine further includes a cooling air supply arrangement which accepts a flow of compressed air and supplies the compressed air to the nozzles for delivery into the cavity. The cooling air supply arrangement and the nozzles are configured such that the inlet swirl angle of the air delivered into the cavity can be varied between a first inlet swirl angle and a second inlet swirl angle. | 09-13-2012 |
20120301272 | VORTEX REDUCER - The present disclosure relates to a vortex reducer ( | 11-29-2012 |
Timothy John Scanlon, Derby GB
Patent application number | Description | Published |
---|---|---|
20140112757 | CLEARANCE CONTROL - A clearance control device including a segment having a passage to deliver fluid towards a component rotating past the segment. Also a fluid flow device having a first fluid path coupled to the passage and a second fluid path that is decoupled from the passage. A first plasma generator is located in the fluid flow device that directs fluid towards the first fluid path; a second plasma generator is located in the fluid flow device that directs fluid towards the second fluid path; and a control arrangement is configured to alternately energise the first and second plasma generators at an energising frequency to deliver fluid to the passage at a frequency coincident with the passing frequency of the component. | 04-24-2014 |
20150047359 | AXIAL FLOW MACHINE COOLING SYSTEM - This invention concerns a system for cooling components in a gas turbine engine, the gas turbine engine including a compressor for driving a primary gas flow to a combustor and a turbine arranged to be driven by combustion gases from the combustor, wherein the system includes: an annular cooling flow passage arranged for fluid communication between the compressor and the turbine, the flow passage having a first inlet arranged to receive gas from the primary gas flow downstream of compressor, and a second inlet located upstream of the first inlet, wherein the annular cooling flow passage has at least one internal wall for guiding airflow from the first inlet towards the airflow from the second inlet, the airflow from the first and second inlets coalesce within the annular flow passage prior to passing along the passage in a direction from the compressor to the turbine. | 02-19-2015 |